Table 2

Measures over time for treatment and waitlist control group
T1 T2 T3 T4
Measures Mean SD Mean SD Mean SD Mean SD
IES-R
Avoidence
  NET 17.64 9.19 9.09 5.43 8.45 5.22 9.73 6.20
  WL 15.73 4.08 16.09 3.65 9.36 2.98 8.46 3.30
Intrusion
  NET 16.91 6.88 8.73 4.56 8.36 3.91 7.73 5.10
  WL 17.36 3.17 16.00 4.29 9.00 3.55 8.55 2.77
Hyperarousal
  NET 13.64 4.48 8.00 3.82 7.72 4.13 6.64 4.39
  WL 14.55 3.59 15.09 2.98 9.91 2.88 8.55 2.54
GHQ-28
  NET 9.45 5.05 3.00 3.38 2.82 3.63 2.73 3.35
  WL 13.27 6.94 13.64 5.75 5.55 3.45 5.09 2.70
HADS
Anxiety
  NET 8.45 3.86 5.27 2.83 5.00 2.53 5.45 3.03
  WL 9.55 4.91 8.64 3.56 5.00 3.16 4.82 2.48
Depression
  NET 8.18 4.21 4.18 2.36 5.00 2.68 4.91 3.02
  WL 7.09 3.21 7.09 2.95 4.00 2.24 3.73 2.10
CiOQ
Positive
  NET 24.82 3.66 26.91 2.43 27.45 2.11 28.00 1.79
  WL 26.82 2.27 26.73 2.33 28.27 2.24 28.09 2.12
Negative
  NET 16.55 7.92 11.82 5.78 11.09 6.07 10.64 4.25
  WL 15.00 7.25 15.82 6.84 11.36 5.82 9.90 3.18
MSPSS
  NET 60.64 13.06 62.00 11.57 60.64 10.86 61.27 11.72
  WL 61.00 6.96 58.91 5.77 60.18 9.38 57.55 5.50
SCSQ
Active
  NET 23.45 7.93 25.09 6.77 23.45 6.07 23.82 8.57
  WL 24.18 5.96 23.09 5.39 24.73 4.08 24.18 5.10
Passive
  NET 11.18 4.29 10.27 3.23 10.45 3.45 10.09 2.84
  WL 11.45 2.58 11.73 2.97 10.82 2.96 10.45 1.57

Zang et al.

Zang et al. BMC Psychiatry 2013 13:41   doi:10.1186/1471-244X-13-41

Open Data